Conversely, in lung and breast cancer, elevated CHAC2 correlates with advanced tumor stage and grade, indicating a worse prognosis (Chand et al., 2022; 2022; Liu et al., 2017; Peng et al., 2023). This evidence concerns the gene CHAC2 and neoplasm.